The Lancet· Jasper Boeddinghaus, Paolo Bima, Luca Crisanti, Dagmar I Keller, Ksenija Slankamenac, Michael Christ, Philipp Schuetz, Andrea Wiencierz, Ivo Strebel, Julia Reinhardt, Iryna Vyshnevska, Tzu-Ying Tsao, Maria Pia Ruggieri, Stephan Steuer, Òscar Miró, Veli-Pekka Harjola, Fulvio Morello, Peiman Nazerian, Dominik Roth, José L Zamorano, Deborah E Gannon, Jason Pott, Ben Bloom, Rafique Zubaid, Richina Bicette, Andreea Cuculici, Héctor Bueno, Juan Sanchis, Felix Mahfoud, Mohammed O A Abubakr, Hyun Suk Yang, Christian Mueller, for the PRESC1SE-MI investigators·· 2026-08-29评分42
[Articles] 急诊科心肌梗死 0/1 h 路径的安全性与有效性：一项国际、实用性、阶梯楔形、整群随机对照试验
[Articles] Safety and efficacy of the 0/1 h pathway for myocardial infarction in the emergency department: an international, pragmatic, stepped-wedge, cluster-randomised, controlled trial
导读
一项国际整群随机对照试验显示，与0/3 h路径相比，实施0/1 h路径达到了30天复合安全性结局的预设非劣效标准，但未能缩短急诊科停留时间。该试验在急诊科环境中评估了心肌梗死的快速诊断路径。研究结果表明，单独实施0/1 h路径不应被期望能改善急诊科的患者流转效率。
来源：The Lancet · thelancet.com